6505--770-25-1-801-0019 -National CMOP BUDESONIDE -(VA-25-00010963)

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is seeking to procure budesonide 0.5mg/2ml inhalation suspension for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The solicitation requires potential offerors to submit a signed SF 1449, pricing schedule, valid state wholesale distributor license, and Trade Agreement Act (TAA) certificate. Only TAA-compliant National Drug Codes (NDCs) will be acceptable, with specific exclusions for products from manufacturer Nephron. Evaluation criteria will focus on compliance with technical specifications, including requirements for bar coding, therapeutic equivalence, and recall procedures. Vendors must ensure products are shippable by the U.S. Postal Service and meet all specified delivery terms. The solicitation was posted on November 1, 2024, with proposals due by November 8, 2024, at 3:00 PM Central Standard Time.

The contract opportunity is not designated as a specific small business set-aside, though the NAICS category is Pharmaceutical Preparation Manufacturing (325412). The total procurement quantity is 16,900 units, to be distributed across multiple CMOP facilities. Vendors must note any product expiration dates that are less than one year from the delivery date. While no specific budget range is explicitly stated, the solicitation covers pharmaceutical products for national distribution within the Veterans Health Administration network. Delivery will be made to multiple CMOP locations, with strict requirements for product quality, packaging, and documentation. The procurement falls under Product Service Code 6505 for Drugs and Biologicals, indicating a specialized pharmaceutical supply contract for veteran healthcare services.